When viewing this topic in a different language, you may notice some differences in the way the content is structured, but it still reflects the latest evidence-based guidance.

Common toxic plant ingestions

Última revisão das evidências: 14 Apr 2026
Última atualização do tópico: 10 Apr 2024

Resumo

Definição

História e exame físico

Principais fatores diagnósticos

  • tachycardia
  • hypertension
  • hypotension
  • miosis
  • mydriasis
  • bradycardia
  • altered mental state
  • hallucinations
  • seizures
Detalhes completos

Outros fatores diagnósticos

  • nausea
  • vomiting
  • abdominal pain
  • diarrhea
  • dyspnea
  • skin flushing
  • dermatitis
  • dermatologic/mucosal irritation
  • visible bleeding: epistaxis, melena, hematuria, hematemesis, hemoptysis
  • headache
  • chest pain
  • muscle pain/swelling
  • skin pallor
  • easy bruising
  • petechial spotting
  • jaundice
  • asterixis
  • ascites
  • palmar erythema
  • spider angiomata
  • diaphoresis
  • dry skin
  • fever
  • urinary retention
  • constipation
  • hyperventilation
  • fasciculations
  • neuromuscular weakness
  • altered sensation
Detalhes completos

Fatores de risco

  • foraging for wild plants to eat
  • brewing wild plants into tea
  • children found or suspected of ingesting plants
Detalhes completos

Investigações diagnósticas

Primeiras investigações a serem solicitadas

  • ECG
  • CBC
  • serum electrolytes
  • serum creatinine
  • serum lactate
  • serum BUN/creatinine ratio
  • liver function tests
  • INR
  • ABG
  • chest x-ray
Detalhes completos

Investigações a serem consideradas

  • troponin
  • serum digoxin levels
  • response to physostigmine
Detalhes completos

Algoritmo de tratamento

AGUDA

all patients

Colaboradores

Autores

Susan Smolinske, PharmD, DABAT, FAACT

Clinical Consultant

New Mexico Poison and Drug Information Center

Adjunct Professor

Pharmacy Practice and Administrative Sciences

University of New Mexico

Albuquerque

NM

Declarações

SS is a member of the ToxED advisory board and consults with webPOISONCONTROL.

Cynthia K. Aaron, MD

Medical Director

Program Director Medical Toxicology

Regional Poison Center at Children's Hospital of Michigan

Professor of Emergency Medicine and Pediatrics

Wayne State University School of Medicine

Detroit

MI

Declarações

CKA owns personal stock in Merck. CKA was on the State of Michigan Public Health Advisory Council for 3 years, and consults with RubiconMD.

Agradecimentos

Dr Susan Smolinske and Dr Cynthia K. Aaron would like to gratefully acknowledge Dr Gerald F. O'Malley and Dr Rika N. O'Malley, previous contributors to this topic.

Declarações

GFOM and RNOM declare that they have no competing interests.

Revisores

Jessamine Soderstrom, MD, MBBS, FACEM

Clinical Toxicologist

Emergency Consultant

Emergency Department

Royal Perth Hospital

Perth

Australia

Declarações

JS declares that she has no competing interests.

Scott Phillips, MD

Clinical Faculty

Department of Toxicology

Rocky Mountain Poison & Drug Center

Denver

CO

Declarações

SP declares that he has no competing interests.

Judith Alsop, PharmD, DABAT

Poison Center Director

California Poison Control System, Sacramento Division

University of California Davis Medical Center

Sacramento

Associate Clinical Professor of Pharmacy

University of California San Francisco School of Pharmacy

San Francisco

Clinical Professor of Medicine

Volunteer Clinical Faculty

University of California Davis School of Medicine

Sacramento

CA

Declarações

JA declares that she has no competing interests.

Créditos aos pareceristas

Os tópicos do BMJ Best Practice são constantemente atualizados, seguindo os desenvolvimentos das evidências e das diretrizes. Os pareceristas aqui listados revisaram o conteúdo pelo menos uma vez durante a história do tópico.

Declarações

As afiliações e declarações dos pareceristas referem--se ao momento da revisão.

Referências

Nossas equipes internas de editoria e de evidências trabalham em conjunto com colaboradores internacionais especializados e pares revisores para garantir que forneçamos acesso às informações o mais clinicamente relevantes possível.

Principais artigos

Froberg B, Ibrahim D, Furbee RB. Plant poisoning. Emerg Med Clin North Am. 2007 May;25(2):375-433. Resumo

Gummin DD, Mowry JB, Beuhler MC, et al. 2022 Annual report of the National Poison Data System(®) (NPDS) from America's Poison Centers(®): 40th annual report. Clin Toxicol (Phila). 2023 Oct;61(10):717-939.Texto completo  Resumo

Halpern JH. Hallucinogens and dissociative agents naturally growing in the United States. Pharmacol Ther. 2004 May;102(2):131-8. Resumo

Gowdy JM. Stramonium intoxication: review of symptomatology in 212 cases. JAMA. 1972 Aug 7;221(6):585-7. Resumo

Burkhard PR, Burkhardt K, Haenggeli CA, et al. Plant-induced seizures: reappearance of an old problem. J Neurol. 1999 Aug;246(8):667-70. Resumo

Artigos de referência

Uma lista completa das fontes referenciadas neste tópico está disponível para os usuários com acesso total ao BMJ Best Practice.

O uso deste conteúdo está sujeito ao nosso aviso legal